Persisters constitute a subpopulation of bacteria that can tolerate lethal concentrations 18 of antibiotics. Multiple mechanisms have been suggested for bacterial persistence 19 against antibiotics. With mycobacteria being no exception to this behaviour, we had 20 reported the de novo emergence of genetically antibiotic-resistant Mycobacterium 21 tuberculosis from persister cells upon prolonged exposure to microbicidal 22 concentrations of the anti-tuberculosis drugs, rifampicin and moxifloxacin. Here, we 23 present evidence for reduced permeability to rifampicin as a mechanism for 24 persistence of Mycobacterium tuberculosis in vitro. We observed that rifampicin 25 persistent M. tuberculosis cells developed a thick outer layer (TOL) capsule. The TOL 26 restricted the entry of fluorochrome-conjugated rifampicin, 5-carboxyfluorescein-27 rifampicin (5-FAM-rifampicin), which retained only 2.5% of its original bactericidal 28 activity, but high levels of permeability, on actively growing mid-log phase cells. Gentle 29 mechanical removal of TOL significantly enhanced 5-FAM-rifampicin entry into the 30 persister cells. The level of 5-FAM-rifampicin in the persister cells was not affected by 31 the pre-incubation of the cells with verapamil, a drug efflux pump inhibitor, ruling out 32 the involvement of efflux pumps in the reduced intracellular concentration of 5-FAM-33 rifampicin. GC-MS analysis of TOL showed the presence of ~7-fold, ~5-fold and ~2-34 fold higher levels of α-D-glucopyranoside, 1,2,5-linked-mannitol, and 3,4-linked 35 mannose, respectively, among ~2-fold higher levels of derivatives of several other 36 types of sugars such as arabinose and galactose. Taken together, the present study 37 reveals that rifampicin-persistent M. tuberculosis cells develop TOL that enables the 38 bacilli to restrict entry of rifampicin and thereby remain tolerant to the antibiotic in vitro.
INTRODUCTION
Mycobacterium tuberculosis, which is the causative agent of tuberculosis, is one of the 42 most successful human pathogens due to its ability to survive under diverse extreme Estimation of zeta potential of mycobacterial persister cells 141 For the determination of surface charge of M. tuberculosis cells, aliquots of the culture 142 were withdrawn on different days during rifampicin treatment and washed once with 143 Middlebrook 7H9 broth. Cells were resuspended in fresh medium and used for zeta 144 potential measurement using zeta sizer nano series (Nano-ZS90, Malvern 145 Instruments). For the estimation of the isoelectric point of the cells, the cells were 146 resuspended in solutions of varying pH from 2 to 10 in PPMS buffer (40 mM of 147 K2HPO4, 20 mM of KH2PO4, and 1.5 mM of MgSO4.7H2O per litre of Milli Q water, pH 148 adjusted using HCl or NaOH). Zeta potential values of the cells at different pH were 149 calculated and the graph was plotted, as described (17, 18) . Flow cytometry analysis 174 Cell suspension (500 µl) was exposed to 1.5 µg/ml of 5-FAM-rifampicin and incubated 175 at 37ºC incubator for 1 hr in the dark. Aliquots were collected at specified intervals and 176 cells were harvested by centrifugation at 12000 x g for 5 min at 4ºC and washed once 177 with ice-cold Middlebrook 7H9 broth and used for flow cytometry analysis. For bead 178 beating, 20 ml culture was incubated with 10 grams of glass beads (4 mm) at 37ºC for 179 15 min at 50 rpm prior to the addition of 5-FAM-rifampicin and processed similarly for 180 flow cytometry with 488 nm solid state laser and 527/32 nm emission filter (for GFP) 181 at low or medium flow rate. For relative permeability estimation of rifampicin persisters 182 for 5-FAM-rifampicin, cells from MLP, persistence phase and verapamil-pretreated (50 183 µg/ml) persisters were incubated with 1.5 µg/ml of 5-FAM-rifampicin and incubated for 184 1 hr at 37ºC in the dark and processed in the same way as described earlier.
185
For CFW staining and OL analysis, 500 µl aliquots of the cells before and after 186 bead beating were incubated with 1:1000 dilutions of CFW (0.1% solution, Sigma) for 
5-FAM-rifampicin permeability assay 212
To estimate the extent of 5-FAM-rifampicin entry into MLP cells and rifampicin 213 persisters, cultures were treated with a final concentration of 1.5 µg/ml of the drug 214 conjugate in 20 ml culture and incubated in a shaker at 37°C. Cultures for both (MLP 215 and persisters) were mildly beaten with 4 mm glass beads to remove the outer 216 capsular layer, as a control for the experiment. Aliquots were taken at every 15 min 217 intervals and quickly washed once with ice-cold Middlebrook 7H9 broth and used for 218 flow cytometry analysis using BD FACSVerse system. Samples before 5-FAM-219 rifampicin addition (0 min) were used as the control for autofluorescence and median 220 of fluorescence was kept at 10 2 .
221
To construct a standard graph for 5-FAM-rifampicin entry, MLP cells were 
RESULTS AND DISCUSSION

234
Earlier studies from our laboratory had shown that actively growing MLP M. 235 tuberculosis cells exposed to 10x MBC concentration of rifampicin consistently 236 showed a triphasic response involving killing phase (0 to 10 th day of exposure), 237 persistence phase (10 th to 15 th day of exposure), followed by regrowth phase (beyond 238 15 th day of exposure) (12). As part of our earlier characterisation of the triphasic 239 response of M. tuberculosis cells to 10x MBC rifampicin, we had found that the 240 rifampicin concentration stays at ~5x MBC even on the 15 th day of the prolonged 241 exposure that spanned for 20 days (12). Therefore, for the present ultrastructural 242 studies, the persistence phase cells from the 12 th day of exposure to 10x MBC 243 rifampicin were used. stained with tannic acid-lead citrate combination (13), showed a significantly thick, but 248 strikingly uneven, loosely bound and deeply stained outer layer (OL) ( Fig. 1A) . On the 249 contrary, the MLP cells (control) showed an evenly thin outer layer, which we called 250 normal outer layer (NOL) (Fig. 1B) . The TOL thickness of persister cells ranged 251 between 25-130 nm (n = 27), while the MLP cells showed a more-or-less evenly thin 252 layer of NOL with an average thickness of ~20 nm (Fig. 1C) . However, the thickness 253 of electron transparent layer (ETL) of the persister and the control cells were found 254 comparable and were morphologically like the already published data ( Fig. 1D) to rifampicin did not show any TOL (Fig. S1) . Thus, the ultrastructural difference 258 between the rifampicin persister cells and the control cells was confined to the outer 259 layer (OL) thickness.
260
Transmission electron microscopy of persister and MLP cells stained with 261 ruthenium red was performed to specifically stain polysaccharides for detection (14) . presence of polysaccharides was further confirmed by staining with a polysaccharide 266 specific fluorophore, calcofluor white (CFW; 23, 24) ( Fig. 1E, top panel) . The persister 267 cells, which were gently bead beaten to remove OL, as described (19), and stained 268 with CFW, showed loss of CFW fluorescence (Fig. 1E, bottom panel) . Flow cytometry 269 analysis of CFW stained native and bead beaten persister cells also showed loss of 270 CFW fluorescence. However, the MLP cells ( Fig. 1F, H were subjected to phase separation between highly hydrophobic hexadecane and 283 aqueous buffer to measure cell-surface hydrophobicity, as described (15). The cells 284 retained in the aqueous phase after the phase extraction reflects the proportion of cells 285 that have a hydrophilic surface. We observed that an average 7% of the persister 286 population was hydrophilic and retained in the aqueous phase, while only 0.03% of 287 MLP cells being hydrophilic ( Fig. 2A) . This showed that the persister population 288 contained a relatively higher proportion of cells having hydrophilic surface. (Fig. 2C) . 311 In order to determine ionic properties of the mycobacterial TOL, the isoelectric indicating that the pI of MLP cells were between pH 4.0 and pH 6.0 (Fig. 2D) . The 318 persistence phase cells showed a similar pI profile with a lower ZP value at high pH 319 ( Fig. 2E) . Although the cells in the killing phase also showed a similar pI, the extent of 320 negative ZP potential at high pH was considerably lesser than that of the persistence 321 phase cells ( Fig. 2F) . Thus, M. tuberculosis cells from MLP, killing and persistence 322 phases showed similar pI values with a varying surface charge at higher pH, probably Table 1 . We observed ~5-fold increase in the levels of 1, 2, 5-mannitol 337 and ~6-7-fold increase in the α-D-glucopyranoside levels. This composition is 338 consistent with an earlier study that the NOL of actively growing M. tuberculosis (19) . 339 The thickening of the OL has caused several fold increase in the levels of the 340 constituents that were present in the NOL of MLP cells (see Table 1 ). For instance, 341 the 6-7-fold higher levels of α-D-glucopyranoside, as a breakdown product in the GC- formed on the two aliphatic hydroxyl group on rifampicin molecule (Fig. 3A) . 5-FAM 371 group was selected due to the nonpolar nature and smaller size of the fluorophore.
372
This was to avoid any kind of alteration in the polarity of the molecule and to minimise 373 the molecular size to maintain its entry into rifampicin-unexposed cells. Thus, it is like 374 rifampicin, which is nonpolar in nature and believed to passively diffuse through the 375 mycobacterial cell wall and accumulate inside the mycobacterial cell within 20 min of 376 exposure (37). Further, the conjugation of 5-FAM to rifampicin reduced the bactericidal 377 activity of the antibiotic to 2.5% of its original bioactivity, as calculated from the bio-378 assay ( Fig. 3B; Fig. S3 ). An average zone of inhibition of 1.77 ± 0.035 cm was (Fig. 3C, D) . The extent of increase in the permeability showed a linear 387 correlation to the concentration of 5-FAM-rifampicin (Fig. 3E) . This indicated that the 388 conjugation of 5-FAM to rifampicin did not affect its uptake by the actively growing 389 MLP cells. The permeability characteristics of 5-FAM-rifampicin into MLP cells 390 validated that the uptake of 5-FAM-rifampicin by the persister cells could be 391 considered as a measure of its extent of permeability into the persister cells as well, 392 in comparison to MLP cells.
393
MLP and persister cells were incubated with 1.5 µg/ml (concentration equivalent 394 to 10x MBC rifampicin used in our earlier study; 12) of 5-FAM-rifampicin and analysed 395 using fluorescence microscopy. The low levels of fluorescence in the persister cells, 396 as compared to that in the MLP cells, indicated restricted entry of 5-FAM-rifampicin 397 into persister cells (Fig. 4A) . Fluorescence microscopy of persister cells, which were 398 gently bead beaten to remove TOL and incubated with 5-FAM-rifampicin, showed 399 enhanced levels of 5-FAM fluorescence indicating increased 5-FAM-rifampicin entry 400 into the persister cells ( Fig. 4B) . Further, we determined the relative time-dependent 401 entry of 5-FAM-rifampicin into MLP and persister cells, with or without bead beating.
402
For this purpose, the cells were incubated over a period of one hour with 1.5 µg/ml of OL of MLP cells did not play any role in the permeability of 5-FAM-rifampicin ( Fig. 4C,   407 E, G). On the contrary, incubation of persister cells with 5-FAM-rifampicin did not show 408 any noticeable fluorescence inside the cells (Fig. 4D, F upper panels, H) . This 409 indicated restricted permeability of the rifampicin conjugate into the cells. Whereas, 410 the bead beaten rifampicin persisters showed a significant time-dependent increase 411 in the fluorescence for at least upto first 30 min of incubation, followed by a level of 412 saturation, suggesting the increased permeability of 5-FAM-rifampicin (Fig. 4D, F   413   lower panels, H) . Thus, the removal of the TOL by bead beating allowed permeability 414 of 5-FAM-rifampicin into the persister cells. These experiments confirmed the 415 substantial role of TOL to function as a 'barrier' to restrict permeability of rifampicin 416 into persister cells.
418
Verapamil did not affect the permeability of persisters to 5-FAM-rifampicin 419 Multidrug efflux pumps are known to contribute to antibiotic tolerance in M. 420 tuberculosis (38-40). It was reported that after incubation of rifampicin-exposed M. 421 tuberculosis cells in in vitro cultures and in infected macrophages with the efflux pump 422 inhibitor, verapamil, rifampicin levels inside the cells increased thereby enhancing 423 susceptibility (41, 42). This study showed that verapamil-sensitive efflux pump was 424 involved in the removal of rifampicin from the cells. With this background information, 425 it was of interest to find out whether efflux pumps were involved in the tolerance of M. 426 tuberculosis persister cells to rifampicin in vitro. 427 For this purpose, we exposed rifampicin persister cells to 50 µg/ml of verapamil 428 and used for 5-FAM-rifampicin permeability assay. We did not observe any difference 429 in terms of the 5-FAM-rifampicin fluorescence intensity of verapamil-treated and 430 untreated rifampicin persister cell samples ( Fig. 5 A, B, C) . It ruled out the possibility 431 of rifampicin efflux as a possible mechanism for the rifampicin-tolerance in persister 432 cells in vitro and further confirmed that the TOL plays a substantial role in the reduced 433 rifampicin permeability into M. tuberculosis persister cells. On the contrary, verapamil 434 was found to be an efflux inhibitor in M. tuberculosis infected mice, zebra fish and 435 macrophages (40, 43). This apparent contradiction with these works is probably due 436 to the difference in the physiological status of the cells exposed to verapamil. While 437 the cells were in the persistence phase in our study, the cells were in the infected 438 animal model and macrophages in the other studies (40, 43). another role for OL in the rifampicin tolerance by persisters.
457
The strategy seemed to be to increase the levels of polysaccharide components 
